Latest Earnings Results: Q2 '26
Estimated EPS
$0.05
Reported EPS
$0.02
Surprise
-61.35%
Estimated Rev
$4.02B
Reported Rev
$4.14B
Surprise
+3.02%
$TEVA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.49 down -296.00% YoY • Reported revenue of $4.14B down -0.81% YoY • Teva Pharmaceutical Industries Ltd. expects 2026 revenue of $16.5-$16.85 billion, non-GAAP operating income of $3.8-$4.0 billion, and non-GAAP diluted EPS of $1.91-$2.11, while maintaining its free cash flow outlook.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.71 | -- | -- | N/A |
Q2 '26 | $0.05 | $0.02 | -61.35% | MISSED |
Q1 '26 | $0.46 | $0.53 | 15.81% | BEAT |
Q4 '25 | $0.64 | $0.96 | 49.71% | BEAT |
Q3 '25 | $0.68 | $0.78 | 15.54% | BEAT |